Oxytocin Modulates Amygdala Reactivity to Masked Fearful Eyes

Neuropsychopharmacology

Volumn 40, Issue 11, 2015, Pages 2632-2638

  Kanat, Manuela ^a   Heinrichs, Markus ^a   Mader, Irina ^a,b   Van Elst, Ludger Tebartz ^a   Domes, Gregor ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OXYTOCIN; PLACEBO; PSYCHOTROPIC AGENT;

ADULT; ALERTNESS; AMYGDALA REACTIVITY; AMYGDALOID NUCLEUS; ARTICLE; ASSOCIATION; AWARENESS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FACIAL EXPRESSION; FEAR; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN EXPERIMENT; MALE; MASKED FEARFUL EYE; NEUROMODULATION; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; THREAT; AMYGDALA; BRAIN MAPPING; DRUG EFFECTS; FACIAL RECOGNITION; INTRANASAL DRUG ADMINISTRATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOSTIMULATION; PHYSIOLOGY; PROCEDURES; RANDOMIZATION; YOUNG ADULT;

ADMINISTRATION, INTRANASAL; AMYGDALA; BRAIN MAPPING; CUES; FACIAL RECOGNITION; FEAR; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; OXYTOCIN; PHOTIC STIMULATION; PSYCHOTROPIC DRUGS; RANDOM ALLOCATION; YOUNG ADULT;

EID: 84941316298     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2015.111     Document Type: Article

References (50)

1. Adolphs R, Gosselin F, Buchanan TW, Tranel D, Schyns P, Damasio AR (2005). A mechanism for impaired fear recognition after amygdala damage. Nature 433: 68-72.
2. Baumgartner T, Heinrichs M, Vonlanthen A, Fischbacher U, Fehr E (2008). Oxytocin shapes the neural circuitry of trust and trust adaptation in humans. Neuron 58: 639-650.
3. Bertsch K, Gamer M, Schmidt B, Schmidinger I, Walther S, Kästel T et al (2013). Oxytocin and reduction of social threat hypersensitivity in women with borDerline personality disorDer. Am J Psychiatry 170: 1169-1177.
4. Breiter HC, Etcoff NL, Whalen PJ, Kennedy WA, Rauch SL, Buckner RL et al (1996). Response and habituation of the human amygdala during visual processing of facial expression. Neuron 17: 875-887.
5. Dodhia S, Hosanagar A, Fitzgerald DA, Labuschagne I, Wood AG, Nathan PJ et al (2014). Modulation of resting-state amygdalafrontal functional connectivity by oxytocin in generalized social anxiety disorDer. Neuropsychopharmacology 39: 2061-2069.
6. Domes G, Heinrichs M, Gläscher J, Büchel C, Braus DF, Herpertz SC (2007a). Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biol Psychiatry 62: 1187-1190.
7. Domes G, Heinrichs M, Michel A, Berger C, Herpertz SC (2007b). Oxytocin improves 'mind-reading' in humans. Biol Psychiatry 61: 731-733.
8. Domes G, Sibold M, Schulze L, Lischke A, Herpertz SC, Heinrichs M (2013a). Intranasal oxytocin increases covert attention to positive social cues. Psychol Med 43: 1747-1753.
9. Domes G, Steiner A, Porges SW, Heinrichs M (2013b). Oxytocin differentially modulates eye gaze to naturalistic social signals of happiness and anger. Psychoneuroendocrinology 38: 1198-1202.
10. Eickhoff SB, Stephan KE, Mohlberg H, Grefkes C, Fink GR, Amunts K et al (2005). A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. Neuroimage 25: 1325-1335.
11. Ellenbogen MA, Linnen A-M, Grumet R, Cardoso C, Joober R (2012). The acute effects of intranasal oxytocin on automatic and effortful attentional shifting to emotional faces. Psychophysiology 49: 128-137.
12. Etkin A, Klemenhagen KC, Dudman JT, Rogan MT, Hen R, KanDel ER et al (2004). Individual differences in trait anxiety predict the response of the basolateral amygdala to unconsciously processed fearful faces. Neuron 44: 1043-1055.
13. Fox E, CalDer AJ, Mathews A, Yiend J (2007). Anxiety and sensitivity to gaze direction in emotionally expressive faces. Emotion 7: 478-486.
14. Gamer M, Buchel C (2009). Amygdala activation predicts gaze toward fearful eyes. J Neurosci 29: 9123-9126.
15. Gamer M, Zurowski B, Buchel C (2010). Different amygdala subregions mediate valence-related and attentional effects of oxytocin in humans. Proc Natl Acad Sci USA 107: 9400-9405.
16. Guastella AJ, Mitchell PB, Dadds MR (2008). Oxytocin increases gaze to the eye region of human faces. Biol Psychiatry 63: 3-5.
17. HarDee JE, Thompson JC, Puce A (2008). The left amygdala knows fear: laterality in the amygdala response to fearful eyes. Soc Cogn Affect Neurosci 3: 47-54.
18. Heinrichs M, Dawans B, Von, Domes G (2009). Oxytocin, vasopressin, and human social behavior. Front Neuroendocrinol 30: 548-557.
19. Hurlemann R, Walter H, Rehme AK, Kukolja J, Santoro SC, Schmidt C et al (2010). Human amygdala reactivity is diminished by the ?-noradrenergic antagonist propranolol. Psychol Med 40: 1839-1848.
20. Kanat M, Heinrichs M, Domes G (2014). Oxytocin and the social brain: neural mechanisms and perspectives in human research. Brain Res 1580: 160-171.
21. Kanat M, Heinrichs M, Schwarzwald R, Domes G (2015). Oxytocin attenuates neural reactivity to masked threat cues from the eyes. Neuropsychopharmacology 40: 287-295.
22. Kim MJ, Loucks RA, Neta M, Davis FC, Oler JA, Mazzulla EC et al (2010). Behind the mask: the influence of mask-type on amygdala response to fearful faces. Soc Cogn Affect Neurosci 5: 363-368.
23. Kim MJ, Loucks RA, Palmer AL, Brown AC, Solomon KM, Marchante AN et al (2011). The structural and functional connectivity of the amygdala: From normal emotion to pathological anxiety. Behav Brain Res 223: 403-410.
24. Kirsch P, Esslinger C, Chen Q, Mier D, Lis S, Siddhanti S et al (2005). Oxytocin modulates neural circuitry for social cognition and fear in humans. J Neurosci 25: 11489-11493.
25. Koch SBJ, ZuiDen M, Van, Nawijn L, Frijling JL, Veltman DJ, Olff M (2014). Intranasal oxytocin as strategy for medication-enhanced psychotherapy of PTSD: Salience processing and fear inhibition processes. Psychoneuroendocrinology 40: 242-256.
26. Labuschagne I, Phan KL, Wood A, Angstadt M, Chua P, Heinrichs M et al (2010). Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorDer. Neuropsychopharmacology 35: 2403-2413.
27. LidDell BJ, Brown KJ, Kemp AH, Barton MJ, Das P, Peduto A et al (2005). A direct brainstem-amygdala-cortical 'alarm' system for subliminal signals of fear. Neuroimage 24: 235-243.
28. Meletti S, Cantalupo G, Benuzzi F, Mai R, Tassi L, Gasparini E et al (2012). Fear and happiness in the eyes: an intra-cerebral eventrelated potential study from the human amygdala. Neuropsychologia 50: 44-54.
29. Meyer-LinDenberg A, Domes G, Kirsch P, Heinrichs M (2011). Oxytocin and vasopressin in the human brain: social neuropeptiDes for translational medicine. Nat Rev Neurosci 12: 524-538.
30. Mogg K, Bradley BP (2002). Selective orienting of attention to masked threat faces in social anxiety. Behav Res Ther 40: 1403-1414.
31. Mogg K, Garner M, Bradley BP (2007). Anxiety and orienting of gaze to angry and fearful faces. Biol Psychol 76: 163-169.
32. Morris JS, DeBonis M, Dolan RJ (2002). Human amygdala responses to fearful eyes. Neuroimage 17: 214-222.
33. Morris JS, Öhman A, Dolan RJ (1999). A subcortical pathway to the right amygdala mediating 'unseen' fear. Proc Natl Acad Sci USA 96: 1680-1685.
34. Pessoa L, Adolphs R (2010). Emotion processing and the amygdala: from a 'low road' to 'many roads' of evaluating biological significance. Nat Rev Neurosci 11: 773-783.
35. Petrovic P, Kalisch R, Singer T, Dolan RJ (2008). Oxytocin attenuates affective evaluations of conditioned faces and amygdala activity. J Neurosci 28: 6607-6615.
36. Prehn K, Kazzer P, Lischke A, Heinrichs M, Herpertz SC, Domes G (2013). Effects of intranasal oxytocin on pupil dilation indicate increased salience of socioaffective stimuli. Psychophysiology 50: 528-537.
37. Radke S, Roelofs K, De Bruijn ERA (2013). Acting on anger: social anxiety modulates approach-avoidance tenDencies after oxytocin administration. Psychol Sci 24: 1573-1578.
38. Scheller E, Büchel C, Gamer M (2012). Diagnostic features of emotional expressions are processed preferentially. PLoS One 7: e41792.
39. Schulze L, Lischke A, Greif J, Herpertz SC, Heinrichs M, Domes G (2011). Oxytocin increases recognition of masked emotional faces. Psychoneuroendocrinology 36: 1378-1382.
40. Schulze L, Renneberg B, Lobmaier JS (2013). Gaze perception in social anxiety and social anxiety disorDer. Front Hum Neurosci 7: 872.
41. Steyer R, Schwenkmezger P, Notz P, Eid M (1997). Der Mehrdimensionale Befindlichkeitsfragebogen MDBF [Multidimensional Mood Questionnaire]. Hogrefe: Göttingen, Germany
42. Straube T, Dietrich C, Mothes-Lasch M, Mentzel H-J, Miltner WHR (2010). The volatility of the amygdala response to masked fearful eyes. Hum Brain Mapp 31: 1601-1608.
43. Tamietto M, Pullens P, De GelDer B, Weiskrantz L, Goebel R (2012). Subcortical connections to human amygdala and changes following Destruction of the visual cortex. Curr Biol 22: 1449-1455.
44. Terburg D, Morgan BE, Montoya ER, Hooge IT, Thornton HB, Hariri AR et al (2012). Hypervigilance for fear after basolateral amygdala damage in humans. Transl Psychiatry 2: e115.
45. Tollenaar MS, Chatzimanoli M, Vander Wee NJA, Putman P (2013). Enhanced orienting of attention in response to emotional gaze cues after oxytocin administration in healthy young men. Psychoneuroendocrinology 38: 1797-1802.
46. Troiani V, Price ET, Schultz RT (2014). Unseen fearful faces promote amygdala guidance of attention. Soc Cogn Affect Neurosci 9: 133-140.
47. Tzourio-Mazoyer N, LanDeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N et al (2002). Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15: 273-289.
48. Whalen PJ, Kagan J, Cook RG, Davis FC, Kim H, Polis S et al (2004). Human amygdala responsivity to masked fearful eye whites. Science 306: 2061-2061.
49. Whalen PJ, Rauch SL, Etcoff NL, McInerney SC, Lee MB, Jenike MA (1998). Masked presentations of emotional facial expressions modulate amygdala activity without explicit knowledge. J Neurosci 18: 411-418.
50. Zaitsev M, Hennig J, Speck O (2004). Point spread function mapping with parallel imaging techniques and high acceleration factors: fast, robust, and flexible method for echo-planar imaging distortion correction. Magn Reson Med 52: 1156-1166.